MDA-MB-231/Luc+ breast cancer cells used in this approach highly express VEGF-C, the main lymphangiogenic factor promoting VEGFR-3 activation leading to tumor-associated lymphangiogenesis [26–29]. Here, FLT4 is linked to neoplasm.